Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 2
1998 1
1999 1
2000 1
2001 3
2002 2
2003 1
2004 9
2005 17
2006 17
2007 37
2008 21
2009 23
2010 27
2011 34
2012 32
2013 35
2014 41
2015 33
2016 41
2017 46
2018 49
2019 36
2020 45
2021 48
2022 39
2023 37
2024 41
2025 54
2026 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

707 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.
Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, Gilron I, Haanpää M, Hansson P, Jensen TS, Kamerman PR, Lund K, Moore A, Raja SN, Rice AS, Rowbotham M, Sena E, Siddall P, Smith BH, Wallace M. Finnerup NB, et al. Lancet Neurol. 2015 Feb;14(2):162-73. doi: 10.1016/S1474-4422(14)70251-0. Epub 2015 Jan 7. Lancet Neurol. 2015. PMID: 25575710 Free PMC article.
BACKGROUND: New drug treatments, clinical trials, and standards of quality for assessment of evidence justify an update of evidence-based recommendations for the pharmacological treatment of neuropathic pain. Using the Grading of Recommendations Assessment, Developm …
BACKGROUND: New drug treatments, clinical trials, and standards of quality for assessment of evidence justify an update of evidence-based re …
Neuropathic pain.
Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C, Kalso E, Bennett DL, Dworkin RH, Raja SN. Colloca L, et al. Nat Rev Dis Primers. 2017 Feb 16;3:17002. doi: 10.1038/nrdp.2017.2. Nat Rev Dis Primers. 2017. PMID: 28205574 Free PMC article. Review.
The burden of chronic neuropathic pain seems to be related to the complexity of neuropathic symptoms, poor outcomes and difficult treatment decisions. ...Despite challenges, progress in the understanding of the pathophysiology of neuropathic pain …
The burden of chronic neuropathic pain seems to be related to the complexity of neuropathic symptoms, poor outcomes and …
Neuropathic pain: Evidence based recommendations.
Moisset X. Moisset X. Presse Med. 2024 Jun;53(2):104232. doi: 10.1016/j.lpm.2024.104232. Epub 2024 Apr 17. Presse Med. 2024. PMID: 38641202 Free article. Review.
Neuropathic pain continues to be a significant problem that lacks effective solutions for every single patient. ...By doing so, we can bridge the gap between theory and practice, and enhance the overall care and treatment of individuals suffering from neuropathic …
Neuropathic pain continues to be a significant problem that lacks effective solutions for every single patient. ...By doing so …
Neuropathic pain in cats: Mechanisms and multimodal management.
Rusbridge C. Rusbridge C. J Feline Med Surg. 2024 May;26(5):1098612X241246518. doi: 10.1177/1098612X241246518. J Feline Med Surg. 2024. PMID: 38710218 Free PMC article. Review.
Chronic pain is a significant welfare concern in cats, and neuropathic pain, which arises from aberrant processing of sensory signals within the nervous system, is a subcategory of this type of pain. To comprehend this condition and how multimodal phar …
Chronic pain is a significant welfare concern in cats, and neuropathic pain, which arises from aberrant processing of s …
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R, Alam U, Cooper C, Loban A, Sutherland K, Glover R, Waterhouse S, Turton E, Horspool M, Gandhi R, Maguire D, Jude EB, Ahmed SH, Vas P, Hariman C, McDougall C, Devers M, Tsatlidis V, Johnson M, Rice ASC, Bouhassira D, Bennett DL, Selvarajah D; OPTION-DM trial group. Tesfaye S, et al. Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22. Lancet. 2022. PMID: 36007534 Free PMC article. Clinical Trial.
BACKGROUND: Diabetic peripheral neuropathic pain (DPNP) is common and often distressing. Most guidelines recommend amitriptyline, duloxetine, pregabalin, or gabapentin as initial analgesic treatment for DPNP, but there is little comparative evidence on …
BACKGROUND: Diabetic peripheral neuropathic pain (DPNP) is common and often distressing. Most guidelines recommend amitriptyli …
Pregabalin and gabapentin for pain.
Mathieson S, Lin CC, Underwood M, Eldabe S. Mathieson S, et al. BMJ. 2020 Apr 28;369:m1315. doi: 10.1136/bmj.m1315. BMJ. 2020. PMID: 32345589 Review. No abstract available.
French guidelines for neuropathic pain: An update and commentary.
Moisset X, Bouhassira D, Attal N. Moisset X, et al. Rev Neurol (Paris). 2021 Sep;177(7):834-837. doi: 10.1016/j.neurol.2021.07.004. Epub 2021 Jul 28. Rev Neurol (Paris). 2021. PMID: 34332778 Free article. Review.
Neuropathic pain remains a significant unmet need. French recommendations were updated in 2020. ...Second-line treatments include pregabalin (such position being confirmed by newer studies), tramadol, combinations and psychotherapy as add on, high-concentrati …
Neuropathic pain remains a significant unmet need. French recommendations were updated in 2020. ...Second-line treatments incl …
Is there a role for combined use of gabapentin and pregabalin in pain control? Too good to be true?
Senderovich H, Jeyapragasan G. Senderovich H, et al. Curr Med Res Opin. 2018 Apr;34(4):677-682. doi: 10.1080/03007995.2017.1391756. Epub 2017 Dec 4. Curr Med Res Opin. 2018. PMID: 29023146 Review.
Gabapentin (Neurontin (1) ) and pregabalin (Lyrica (2) ) are first- and second-generation alpha2delta ligands, respectively, and are both approved for use as adjunctive therapy in pain control. Although they do not bind to gamma-aminobutyric acid (GABA) recep …
Gabapentin (Neurontin (1) ) and pregabalin (Lyrica (2) ) are first- and second-generation alpha2delta ligands, respectively, a …
Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis.
Davari M, Amani B, Amani B, Khanijahani A, Akbarzadeh A, Shabestan R. Davari M, et al. Korean J Pain. 2020 Jan 1;33(1):3-12. doi: 10.3344/kjp.2020.33.1.3. Korean J Pain. 2020. PMID: 31888312 Free PMC article. Review.
Neuropathic pain after spinal cord injury (SCI) has a significant negative impact on the patients' quality of life. The objective of this systematic review is to examine the safety and efficacy of pregabalin (PGB) and gabapentin (GBP) in the treatment …
Neuropathic pain after spinal cord injury (SCI) has a significant negative impact on the patients' quality of life. The object …
Etiology and Pharmacology of Neuropathic Pain.
Alles SRA, Smith PA. Alles SRA, et al. Pharmacol Rev. 2018 Apr;70(2):315-347. doi: 10.1124/pr.117.014399. Pharmacol Rev. 2018. PMID: 29500312 Free article. Review.
This leads to central sensitization and aberrant processing such that tactile and innocuous thermal information is perceived as pain (allodynia). Processes involved in the onset of neuropathic pain differ from those involved in its long-term maintenance. ...W …
This leads to central sensitization and aberrant processing such that tactile and innocuous thermal information is perceived as pain …
707 results